EMAGLIFLOZIN M 12.5/1000MG

EMAGLIFLOZIN M 12.5/1000MG is an advanced combination of Empagliflozin 12.5 mg and Metformin Hydrochloride 1000 mg designed for adults with Type 2 Diabetes Mellitus (T2DM) who need stronger blood sugar control.

Empagliflozin (an SGLT2 inhibitor) lowers blood glucose by helping the kidneys remove excess sugar through urine, while Metformin (a biguanide) works by reducing glucose production in the liver and improving insulin sensitivity. Together, this combination targets multiple pathways to help patients achieve and maintain better glycemic control, support weight management, and promote heart and kidney health.

✅ Key Benefits:

• Dual-action formula for enhanced blood sugar management

• May reduce the risk of cardiovascular complications

• Supports weight loss and better insulin sensitivity

• Convenient once or twice daily dosing (as prescribed)

• Suitable for patients who need high-dose Metformin support